Medtronic Inc (MDT:US)

Medtronic Inc News

  • George Bush’s Stent Surgery Revives Debate on Heart Care

    Former President George W. Bush’s decision to allow doctors to use a stent to clear a blocked heart artery, performed absent symptoms, is reviving a national debate on the best way to treat early cardiac concerns.

  • Former President Bush Gets Heart Stent to Open Artery

    Former President George W. Bush received a stent to relieve blockage in a heart artery this morning, and doctors said the procedure was successful with no complications, according to a statement from his office.

  • Medical Device Hackers Find Government Ally to Pressure Industry

    Two years ago, Jay Radcliffe discovered a software bug in his insulin pump that could allow hackers to take remote control of the device. The diabetic and computer security researcher went public with his findings at a hacker conference after the manufacturer, Medtronic Inc., didn't respond to him.

  • FDA Fees to Review Drugs Would Be Unfrozen in House Bill

    About $1 billion in annual fees that Pfizer Inc., Medtronic Inc. and other drug and device companies pay the U.S. to review new products would be exempt from federal budget cuts under a bipartisan bill proposed in Congress.

  • Medtronic Recalls Infusion Pump Linked to 14 Deaths

    Medtronic Inc.’s SynchroMed infusion pumps were found to have four flaws that have led to 14 patient deaths, spurring U.S. regulators to issue their most serious recall on the implantable device used to deliver pain and other medications.

  • Study Gains Put Diabetics Nearer to Artificial Pancreas

    A decade of work by scientists to create an artificial pancreas that will independently control insulin levels in people with Type 1 diabetes took a leap forward in research from Medtronic Inc. and Johnson & Johnson.

  • Medtronic Boosts Divident While Planning Share Buyback

    Medtronic Inc., the largest maker of heart rhythm and spinal devices, increased its stock buyback program by 80 million shares and boosted its quarterly cash dividend to 28 cents per share.

  • Medtronic Insulin Pump Cuts Deadly Night Blood Sugar Lows

    Medtronic Inc.’s advanced insulin pump can safely shut itself off when a patient’s blood sugar gets too low, according to a study hailed as breakthrough in the effort to automate insulin delivery for Type 1 diabetics.

  • U.S. Stocks Fall on IMF Outlook, Warning on Stimulus Exit

    U.S. stocks fell, after yesterday’s rally in the Standard & Poor’s 500 Index, as the International Monetary Fund cut its 2014 outlook for America and urged the central bank to carefully manage its exit from stimulus plans.

  • Medtronic’s Infuse No Better Than Bone Graft With Risk

    Medtronic Inc.’s Infuse, designed to help bones heal after spinal surgery, works no better than a graft and carries side effects including an increased risk of cancer, two independent reviews found.

Sponsored Links
Curation software by Lingospot